272 related articles for article (PubMed ID: 19285272)
1. Procoagulant mechanisms in tumour cells.
Falanga A; Panova-Noeva M; Russo L
Best Pract Res Clin Haematol; 2009 Mar; 22(1):49-60. PubMed ID: 19285272
[TBL] [Abstract][Full Text] [Related]
2. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
3. Microparticles, thrombosis and cancer.
Aharon A; Brenner B
Best Pract Res Clin Haematol; 2009 Mar; 22(1):61-9. PubMed ID: 19285273
[TBL] [Abstract][Full Text] [Related]
4. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
5. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
Falanga A; Marchetti M; Vignoli A; Balducci D
Clin Adv Hematol Oncol; 2003 Nov; 1(11):673-8. PubMed ID: 16258469
[TBL] [Abstract][Full Text] [Related]
6. [Haemostatic aspects in clinical oncology].
Langer F; Holstein K; Eifrig B; Bokemeyer C
Hamostaseologie; 2008 Dec; 28(5):472-80. PubMed ID: 19132177
[TBL] [Abstract][Full Text] [Related]
7. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
Winter PC
Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilia in cancer.
Falanga A
Semin Thromb Hemost; 2005 Feb; 31(1):104-10. PubMed ID: 15706482
[TBL] [Abstract][Full Text] [Related]
10. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
Rak J; Milsom C; Yu J
APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
[TBL] [Abstract][Full Text] [Related]
11. Cancer and thromboembolic disease: pathogenic mechanisms.
Lee AY
Cancer Treat Rev; 2002 Jun; 28(3):137-40. PubMed ID: 12234564
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of thrombosis in patients with malignancy.
Falanga A; Donati MB
Int J Hematol; 2001 Feb; 73(2):137-44. PubMed ID: 11372723
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression.
Castellana D; Kunzelmann C; Freyssinet JM
Hamostaseologie; 2009 Jan; 29(1):51-7. PubMed ID: 19151847
[TBL] [Abstract][Full Text] [Related]
14. Heparin in tumor progression and metastatic dissemination.
Falanga A; Marchetti M
Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis and malignancy: pathogenesis and prevention.
Schwartz JD; Simantov R
In Vivo; 1998; 12(6):619-24. PubMed ID: 9891224
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic regulation of tissue factor and thrombosis in cancer.
Anand M; Brat DJ
Thromb Res; 2012 Apr; 129 Suppl 1():S46-9. PubMed ID: 22682132
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor and cancer.
Milsom C; Rak J
Pathophysiol Haemost Thromb; 2008; 36(3-4):160-76. PubMed ID: 19176989
[TBL] [Abstract][Full Text] [Related]
18. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype.
Nierodzik ML; Karpatkin S
Cancer Cell; 2006 Nov; 10(5):355-62. PubMed ID: 17097558
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of increased risk of thrombosis in cancer.
Kwaan HC; Parmar S; Wang J
Semin Thromb Hemost; 2003 Jun; 29(3):283-90. PubMed ID: 12888932
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of the thrombophilic state in the cancer patient.
Falanga A; Rickles FR
Semin Thromb Hemost; 1999; 25(2):173-82. PubMed ID: 10357085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
